The Deep Dive: Life Sciences

  • Author:
    Geoff Robinson
  • Level: 
    Intermediate to advanced
  • Study time:
    20 minutes
Write your awesome label here.
Course overview
This playlist explores the major forces reshaping biopharma from 2026 to 2030, including patent expiries, biosimilar competition, AI adoption, decentralized clinical trials, supply-chain restructuring, precision medicine, GLP-1 growth, and investment trends. It explains how commercial strategy, innovation, regulation, and capital allocation are evolving across the pharmaceutical industry.

What's included?

  • 1 podcast
  • Understand the forces redefining biopharma growth, risk, and competitive advantage in the years ahead.
  • Insights from a #1 ranked data-driven analyst

Who should watch this playlist? 

This playlist is for investors, analysts, strategy professionals, healthcare executives, and curious learners seeking a structured understanding of biopharma’s next phase. It suits intermediate audiences wanting to connect scientific innovation, market dynamics, regulation, and deal activity to real commercial outcomes and sharper industry decision-making.

Why TheInvestmentAnalyst.com?

We are the only training house that is able to bring top-ranked analyst experience into your classroom. We buck the trend. Most training businesses recruit junior ex-bankers to become their trainer. Our instructors cut their teeth teaching and then gain senior experience with investment banks.

We believe, you could not be in better hands.

New Content Drops

What's trending on the platform now

EMEA Sell-Side Analyst

From the App Store
I've tried tonnes of apps like this, but this one simply worked better in every way possible

Buy-side analyst

From the App Store
What a little gem in the world of financial training. Not the usual rehashed academic stuff, but realistic, practical, immediately applicable, well explained, young and modern financial content

M&A Analyst

From the App Store
The delivery is concise, entertaining and easy to follow

Geoff Robinson
FCA FMVA MFM

Thought leader, instructor, writer, financial influencer, Former UBS Managing Director and 8x #1 ranked analysts EMEA Institutional Investor Survey
ABOUT Geoff
Geoff has had a varied career. He was a Managing Director within UBS Equity Research, leading their Global Fundamental Analytics franchise. During this time, he was #1, ranked 10x in the EMEA Institutional Investor Survey. Before UBS, he was a material equity investor and LBO co-investor in two market exited training consultancies. Geoff has a passion for learning and is well-known for his ability to break down complex subject matter and distil it to an audience in a digestible and engaging manner. He brings this passion to TheInvestmentAnalyst.com. 
Empty space, drag to resize